Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
Clinical trial NCT07074470 · RECRUITING
Trial details
- NCT number
- NCT07074470
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-02
- Primary completion
- 2030-01-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.